Testosterone for women in menopause: when it's used

Testosterone for women in menopause

This is not medical advice — it is general information based on what you searched for that may help.

General information based on published sources and the symptoms you searched for. This isn't medical or legal advice, a diagnosis or a treatment plan. Please consult a doctor about your own symptoms. If your symptoms are severe or sudden, seek urgent care.

This page may not apply to you if:

Testosterone for women is currently an off-label use in the UK and is not FDA-approved for this indication in the US; it should only be prescribed and monitored by a clinician experienced with it

Testosterone is sometimes considered as an addition to hormone therapy for women in menopause, but its evidence-based use is narrower than general marketing around it suggests. NICE guideline NG23 recommends considering testosterone specifically for low sexual desire associated with menopause, when HRT alone is not effective — see our low libido page for the fuller picture of that symptom, and our DHEA evidence verdict for a related hormone sometimes discussed alongside it.

Why it's currently "off-label"

NICE is explicit that this is currently an off-label use of testosterone in the UK — meaning the medication exists and is prescribed, but hasn't gone through the formal approval process specifically for this use in women. That doesn't mean it's experimental or unsafe when properly prescribed; it means the regulatory pathway hasn't caught up with established clinical practice, which is why monitoring by an experienced clinician matters.

What it doesn't treat

Testosterone for women in this context is specifically about low sexual desire, not a general energy, mood, or muscle-building treatment. Be cautious of marketing that implies broader benefits — that's not what the evidence-based guidance actually supports.

How it's typically given, and why that matters

Testosterone for women is usually prescribed in doses far lower than those used for men, often using products formulated for men but dosed down, since women-specific formulations are limited in many markets. This makes monitoring important — your clinician should check levels periodically to avoid excessive dosing. See our hormone pellets page if you're specifically considering a pellet-based delivery method, which carries its own additional concerns around dosing consistency.

What this means for you

This is a conversation to have after HRT alone hasn't resolved low libido, not a first-line addition — and it needs a clinician who will monitor your levels, not a source that doesn't.

Use our treatment conversation builder to raise this directly:

Has HRT alone been given a fair trial for my low libido before considering testosterone?
How would you monitor my testosterone levels if we started it, and how often?

Where are you right now?

Still tracking

Not sure if your symptoms fit? Start tracking your daily patterns.

Log and spot your patterns with the symptom checklist →

Ready to talk to a doctor

Have an upcoming appointment? Bring structured questions and your history.

Prepare your 10-minute doctor appointment questions →

Already on treatment

Evaluating your response or wondering what to adjust next?

Explore evidence-graded treatment and lifestyle options →

Questions people ask

Is testosterone approved for women?

Not specifically for this use. NICE guidance recommends considering testosterone for low sexual desire associated with menopause when HRT alone isn't effective, but notes this is currently an off-label use of testosterone in the UK. It should be prescribed and monitored by a clinician experienced with using it in women, not self-sourced.

What does testosterone treat, specifically?

The main evidence-based use in menopause care is for low sexual desire that hasn't responded to HRT alone. It isn't a general energy, mood, or muscle-mass treatment in this context, and claims along those lines aren't what the guidance actually supports.